P54762 (EPHB1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 143.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Ephrin type-B receptor 1 EC=2.7.10.1 Alternative name(s): ELK EPH tyrosine kinase 2 EPH-like kinase 6 Short name=EK6 Short name=hEK6 Neuronally-expressed EPH-related tyrosine kinase Short name=NET Tyrosine-protein kinase receptor EPH-2 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 984 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Receptor tyrosine kinase which binds promiscuously transmembrane ephrin-B family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Cognate/functional ephrin ligands for this receptor include EFNB1, EFNB2 and EFNB3. During nervous system development, regulates retinal axon guidance redirecting ipsilaterally ventrotemporal retinal ganglion cells axons at the optic chiasm midline. This probably requires repulsive interaction with EFNB2. In the adult nervous system together with EFNB3, regulates chemotaxis, proliferation and polarity of the hippocampus neural progenitors. Beside its role in axon guidance plays also an important redundant role with other ephrin-B receptors in development and maturation of dendritic spines and synapse formation. May also regulate angiogenesis. More generally, may play a role in targeted cell migration and adhesion. Upon activation by EFNB1 and probably other ephrin-B ligands activates the MAPK/ERK and the JNK signaling cascades to regulate cell migration and adhesion respectively. Ref.2 Ref.9 Ref.11 Ref.12 Ref.13 |
| Catalytic activity | ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate. |
| Subunit structure | Heterotetramer upon binding of the ligand. The heterotetramer is composed of an ephrin dimer and a receptor dimer. Oligomerization is probably required to induce biological responses By similarity. Interacts with EPHB6; transphosphorylates EPHB6 to form an active signaling complex. Interacts with PICK1 By similarity. Interacts (through Tyr-594) with NCK1 (via SH2 domain); activates the JUN cascade to regulate cell adhesion By similarity. The ligand-activated form interacts (through Tyr-928) with GRB7 and GRB10 (via SH2 domains). The ligand-activated form interacts (residues within the catalytic domain) with GRB2 (via SH2 domain). Interacts with GRB2, SHC1 and SRC; activates the MAPK/ERK cascade to regulate cell migration. Interacts with CBL; regulates receptor degradation through ubiquitination. Interacts with ACP1. Ref.2 Ref.7 Ref.9 Ref.10 Ref.11 Ref.12 Ref.13 |
| Subcellular location | Cell membrane; Single-pass type I membrane protein. Early endosome membrane. Cell projection › dendrite By similarity Ref.13. |
| Tissue specificity | Preferentially expressed in brain. |
| Post-translational modification | Phosphorylated. Autophosphorylation is stimulated by the ligand EFNB1. Required for interaction with SH2 domain-containing interactors, for activation of the MAPK/ERK and JUN signaling cascades and for ubiquitination by CBL. Ref.7 Ref.11 Ref.13 Ubiquitinated; (EFNB1)ligand-induced poly- and/or multi-ubiquitination by CBL is regulated by SRC and leads to lysosomal degradation. Ref.13 |
| Sequence similarities | Belongs to the protein kinase superfamily. Tyr protein kinase family. Ephrin receptor subfamily. Contains 1 Eph LBD (Eph ligand-binding) domain. Contains 2 fibronectin type-III domains. Contains 1 protein kinase domain. Contains 1 SAM (sterile alpha motif) domain. |
| Sequence caution | The sequence AAB94627.1 differs from that shown. Reason: wrong intron-exon boundaries. The sequence AAB94628.1 differs from that shown. Reason: wrong intron-exon boundaries. The sequence AAD02031.1 differs from that shown. Reason: Chimeric cDNA. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| GRB10 | Q13322 | 2 | EBI-80252,EBI-80275 | |
| GRB2 | P62993 | 2 | EBI-80252,EBI-401755 | |
| GRB7 | Q14451 | 4 | EBI-80252,EBI-970191 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 17 | 17 | Ref.6 | ||||||||||||||||||||||||||||||||
| Chain | 18 – 984 | 967 | Ephrin type-B receptor 1 | PRO_0000016824 | |||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||
| Topological domain | 18 – 540 | 523 | Extracellular Potential | ||||||||||||||||||||||||||||||||
| Transmembrane | 541 – 563 | 23 | Helical; Potential | ||||||||||||||||||||||||||||||||
| Topological domain | 564 – 984 | 421 | Cytoplasmic Potential | ||||||||||||||||||||||||||||||||
| Domain | 19 – 201 | 183 | Eph LBD | ||||||||||||||||||||||||||||||||
| Domain | 323 – 424 | 102 | Fibronectin type-III 1 | ||||||||||||||||||||||||||||||||
| Domain | 430 – 525 | 96 | Fibronectin type-III 2 | ||||||||||||||||||||||||||||||||
| Domain | 619 – 882 | 264 | Protein kinase | ||||||||||||||||||||||||||||||||
| Domain | 911 – 975 | 65 | SAM | ||||||||||||||||||||||||||||||||
| Nucleotide binding | 625 – 633 | 9 | ATP By similarity | ||||||||||||||||||||||||||||||||
| Motif | 982 – 984 | 3 | PDZ-binding Potential | ||||||||||||||||||||||||||||||||
| Compositional bias | 183 – 319 | 137 | Cys-rich | ||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||
| Active site | 744 | 1 | Proton acceptor By similarity | ||||||||||||||||||||||||||||||||
| Binding site | 651 | 1 | ATP Probable | ||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||
| Modified residue | 928 | 1 | Phosphotyrosine; by autocatalysis By similarity | ||||||||||||||||||||||||||||||||
| Glycosylation | 334 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||
| Glycosylation | 426 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||
| Glycosylation | 480 | 1 | N-linked (GlcNAc...) Potential | ||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||
| Natural variant | 18 | 1 | M → V. Ref.16 Corresponds to variant rs55650774 [ dbSNP | Ensembl ]. | VAR_042165 | |||||||||||||||||||||||||||||||
| Natural variant | 87 | 1 | T → S. Corresponds to variant rs1042794 [ dbSNP | Ensembl ]. | VAR_011801 | |||||||||||||||||||||||||||||||
| Natural variant | 152 | 1 | G → R. Corresponds to variant rs1042793 [ dbSNP | Ensembl ]. | VAR_011802 | |||||||||||||||||||||||||||||||
| Natural variant | 367 | 1 | R → G. Corresponds to variant rs1042789 [ dbSNP | Ensembl ]. | VAR_011803 | |||||||||||||||||||||||||||||||
| Natural variant | 387 | 1 | T → M. Ref.16 Corresponds to variant rs56396912 [ dbSNP | Ensembl ]. | VAR_042166 | |||||||||||||||||||||||||||||||
| Natural variant | 485 | 1 | R → S. Corresponds to variant rs1042788 [ dbSNP | Ensembl ]. | VAR_011804 | |||||||||||||||||||||||||||||||
| Natural variant | 707 | 1 | S → T in an ovarian undifferentiated carcinoma sample; somatic mutation. Ref.16 | VAR_042167 | |||||||||||||||||||||||||||||||
| Natural variant | 719 | 1 | I → V in a gastric adenocarcinoma sample; somatic mutation. Ref.16 | VAR_042168 | |||||||||||||||||||||||||||||||
| Natural variant | 743 | 1 | R → Q in a gastric adenocarcinoma sample; somatic mutation. Ref.16 | VAR_042169 | |||||||||||||||||||||||||||||||
| Natural variant | 847 | 1 | M → T. Corresponds to variant rs1042785 [ dbSNP | Ensembl ]. | VAR_011805 | |||||||||||||||||||||||||||||||
| Natural variant | 912 | 1 | A → T. Ref.16 Corresponds to variant rs56345346 [ dbSNP | Ensembl ]. | VAR_042170 | |||||||||||||||||||||||||||||||
| Natural variant | 973 | 1 | R → W. Ref.2 Corresponds to variant rs1042784 [ dbSNP | Ensembl ]. | VAR_058479 | |||||||||||||||||||||||||||||||
| Natural variant | 981 | 1 | T → M. Ref.16 Corresponds to variant rs56186270 [ dbSNP | Ensembl ]. | VAR_042171 | |||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||
| Mutagenesis | 594 | 1 | Y → F: Loss of interaction with NCK1. Ref.2 | ||||||||||||||||||||||||||||||||
| Mutagenesis | 600 | 1 | Y → F: Loss of interaction with SHC1 and SRC. Ref.12 | ||||||||||||||||||||||||||||||||
| Mutagenesis | 651 | 1 | K → R: Kinase-dead mutant. Unable to autophosphorylate, to interact with SH2 domain-containing interactors, to activate the MAPK/ERK and JUN signaling cascades. Not ubiquitinated by CBL. Ref.2 Ref.13 | ||||||||||||||||||||||||||||||||
| Mutagenesis | 778 | 1 | Y → F: Loss of interaction with SHC1. Ref.12 | ||||||||||||||||||||||||||||||||
| Mutagenesis | 928 | 1 | Y → F: Disrupts binding with the GRB10 SH2 domain, providing evidence for phosphorylation. Disrupts interaction with GRB7 and ACP1. Ref.7 Ref.9 Ref.11 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 12 | 1 | A → E in AAD02030. Ref.2 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 12 | 1 | A → E in AAB94627. Ref.2 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 12 | 1 | A → E in AAB94628. Ref.2 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 185 | 1 | S → I in AAD02030. Ref.2 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 185 | 1 | S → I in AAD02031. Ref.2 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 185 | 1 | S → I in AAB94627. Ref.2 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 185 | 1 | S → I in AAB94628. Ref.2 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 274 | 1 | T → R in AAD02030. Ref.2 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 274 | 1 | T → R in AAD02031. Ref.2 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 274 | 1 | T → R in AAB94627. Ref.2 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 274 | 1 | T → R in AAB94628. Ref.2 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 336 | 1 | T → S in AAD02030. Ref.2 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 336 | 1 | T → S in AAD02031. Ref.2 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 336 | 1 | T → S in AAB94627. Ref.2 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 336 | 1 | T → S in AAB94628. Ref.2 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 752 | 1 | V → L in AAI11745. Ref.5 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 813 | 1 | V → H in AAD02030. Ref.2 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 813 | 1 | V → H in AAB94627. Ref.2 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 819 | 1 | S → Y in AAD02030. Ref.2 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 819 | 1 | S → Y in AAB94627. Ref.2 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 881 | 1 | M → I in BAF83897. Ref.3 | ||||||||||||||||||||||||||||||||
| Sequence conflict | 903 | 1 | L → H in BAF83897. Ref.3 | ||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||
| Beta strand | 441 – 445 | 5 | |||||||||||||||||||||||||||||||||
| Beta strand | 447 – 453 | 7 | |||||||||||||||||||||||||||||||||
| Beta strand | 464 – 473 | 10 | |||||||||||||||||||||||||||||||||
| Beta strand | 482 – 495 | 14 | |||||||||||||||||||||||||||||||||
| Beta strand | 501 – 512 | 12 | |||||||||||||||||||||||||||||||||
| Beta strand | 514 – 517 | 4 | |||||||||||||||||||||||||||||||||
| Beta strand | 521 – 524 | 4 | |||||||||||||||||||||||||||||||||
| Helix | 916 – 921 | 6 | |||||||||||||||||||||||||||||||||
| Turn | 922 – 924 | 3 | |||||||||||||||||||||||||||||||||
| Helix | 926 – 928 | 3 | |||||||||||||||||||||||||||||||||
| Helix | 929 – 935 | 7 | |||||||||||||||||||||||||||||||||
| Helix | 940 – 943 | 4 | |||||||||||||||||||||||||||||||||
| Helix | 948 – 954 | 7 | |||||||||||||||||||||||||||||||||
| Helix | 959 – 975 | 17 | |||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "cDNA cloning, molecular characterization, and chromosomal localization of NET(EPHT2), a human EPH-related receptor protein-tyrosine kinase gene preferentially expressed in brain." Tang X.X., Biegel J.A., Nycum L.M., Yoshioka A., Brodeur G.M., Pleasure D.E., Ikegaki N. Genomics 29:426-437(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Fetal brain. |
| [2] | "Nck recruitment to Eph receptor, EphB1/ELK, couples ligand activation to c-Jun kinase." Stein E., Huynh-Do U., Lane A.A., Cerretti D.P., Daniel T.O. J. Biol. Chem. 273:1303-1308(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION IN CELL ADHESION, FUNCTION IN JUN CASCADE ACTIVATION, INTERACTION WITH NCK1, MUTAGENESIS OF TYR-594 AND LYS-651, VARIANT TRP-973. Tissue: Kidney. |
| [3] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [4] | "The DNA sequence, annotation and analysis of human chromosome 3." Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J. Gibbs R.A.Nature 440:1194-1198(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [6] | "Signal peptide prediction based on analysis of experimentally verified cleavage sites." Zhang Z., Henzel W.J. Protein Sci. 13:2819-2824(2004) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 18-32. |
| [7] | "Ligand activation of ELK receptor tyrosine kinase promotes its association with Grb10 and Grb2 in vascular endothelial cells." Stein E., Cerretti D.P., Daniel T.O. J. Biol. Chem. 271:23588-23593(1996) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH GRB2 AND GRB10, MUTAGENESIS OF TYR-928, PHOSPHORYLATION AT TYR-928. |
| [8] | "Unified nomenclature for Eph family receptors and their ligands, the ephrins." Eph nomenclature committee Cell 90:403-404(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NOMENCLATURE. |
| [9] | "Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses." Stein E., Lane A.A., Cerretti D.P., Schoecklmann H.O., Schroff A.D., Van Etten R.L., Daniel T.O. Genes Dev. 12:667-678(1998) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN ANGIOGENESIS, FUNCTION IN CELL ADHESION, INTERACTION WITH ACP1, MUTAGENESIS OF TYR-928. |
| [10] | "The kinase-null EphB6 receptor undergoes transphosphorylation in a complex with EphB1." Freywald A., Sharfe N., Roifman C.M. J. Biol. Chem. 277:3823-3828(2002) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH EPHB6. |
| [11] | "EphB1 associates with Grb7 and regulates cell migration." Han D.C., Shen T.L., Miao H., Wang B., Guan J.L. J. Biol. Chem. 277:45655-45661(2002) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH GRB7, FUNCTION, PHOSPHORYLATION AT TYR-928, MUTAGENESIS OF TYR-928. |
| [12] | "EphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote chemotaxis." Vindis C., Cerretti D.P., Daniel T.O., Huynh-Do U. J. Cell Biol. 162:661-671(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN CELL MIGRATION, FUNCTION IN ERK CASCADE ACTIVATION, INTERACTION WITH GRB2; SHC1 AND SRC, MUTAGENESIS OF TYR-600 AND TYR-778. |
| [13] | "Ligand binding induces Cbl-dependent EphB1 receptor degradation through the lysosomal pathway." Fasen K., Cerretti D.P., Huynh-Do U. Traffic 9:251-266(2008) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION IN ERK CASCADE ACTIVATION, UBIQUITINATION BY CBL, INTERACTION WITH CBL, MUTAGENESIS OF LYS-651, AUTOPHOSPHORYLATION, IDENTIFICATION OF EFNB1 AS LIGAND, SUBCELLULAR LOCATION. |
| [14] | "Solution structure of the C-terminal SAM-domain of mouse ephrin type-B receptor 1 precursor (EC 2.7.1.112)." RIKEN structural genomics initiative (RSGI) Submitted (JUL-2007) to the PDB data bank Cited for: STRUCTURE BY NMR OF 899-984. |
| [15] | "Solution structures of the FN3 domain of human ephrin type-B receptor 1." RIKEN structural genomics initiative (RSGI) Submitted (FEB-2009) to the PDB data bank Cited for: STRUCTURE BY NMR OF 434-528. |
| [16] | "Patterns of somatic mutation in human cancer genomes." Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G. Stratton M.R.Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] VAL-18; MET-387; THR-707; VAL-719; GLN-743; THR-912 AND MET-981. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | L40636 mRNA. Translation: AAB08520.1. AF037331 mRNA. Translation: AAD02030.1. AF037332 mRNA. Translation: AAD02031.1. Sequence problems. AF037333 mRNA. Translation: AAB94627.1. Sequence problems. AF037334 mRNA. Translation: AAB94628.1. Sequence problems. AK291208 mRNA. Translation: BAF83897.1. AC016931 Genomic DNA. No translation available. AC016951 Genomic DNA. No translation available. AC063918 Genomic DNA. No translation available. AC073244 Genomic DNA. No translation available. AC092969 Genomic DNA. No translation available. BC111744 mRNA. Translation: AAI11745.1. | ||||||||||||||||||
| IPI | IPI00008315. | ||||||||||||||||||
| RefSeq | NP_004432.1. NM_004441.4. | ||||||||||||||||||
| UniGene | Hs.116092. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ProteinModelPortal | P54762. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| IntAct | P54762. 6 interactions. | ||||||||||||||||||
| STRING | 9606.ENSP00000381097. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | P54762. | ||||||||||||||||||
Polymorphism databases | |||||||||||||||||||
| DMDM | 1706663. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PaxDb | P54762. | ||||||||||||||||||
| PRIDE | P54762. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| DNASU | 2047. | ||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENST00000398015; ENSP00000381097; ENSG00000154928. | ||||||||||||||||||
| GeneID | 2047. | ||||||||||||||||||
| KEGG | hsa:2047. | ||||||||||||||||||
| UCSC | uc003eqt.3. human. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 2047. | ||||||||||||||||||
| GeneCards | GC03P134316. | ||||||||||||||||||
| HGNC | HGNC:3392. EPHB1. | ||||||||||||||||||
| MIM | 600600. gene. | ||||||||||||||||||
| neXtProt | NX_P54762. | ||||||||||||||||||
| PharmGKB | PA27824. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| eggNOG | COG0515. | ||||||||||||||||||
| HOGENOM | HOG000233856. | ||||||||||||||||||
| HOVERGEN | HBG062180. | ||||||||||||||||||
| InParanoid | P54762. | ||||||||||||||||||
| KO | K05110. | ||||||||||||||||||
| OMA | ELGWTAN. | ||||||||||||||||||
| OrthoDB | EOG4W9J35. | ||||||||||||||||||
| PhylomeDB | P54762. | ||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||
| BRENDA | 2.7.10.1. 2681. | ||||||||||||||||||
| Pathway_Interaction_DB | ephbfwdpathway. EPHB forward signaling. ephrinbrevpathway. Ephrin B reverse signaling. ephrinb_ephbpathway. EphrinB-EPHB pathway. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | P54762. | ||||||||||||||||||
| Bgee | P54762. | ||||||||||||||||||
| CleanEx | HS_EPHB1. | ||||||||||||||||||
| Genevestigator | P54762. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| Gene3D | 1.10.150.50. 1 hit. 2.60.40.10. 2 hits. | ||||||||||||||||||
| InterPro | IPR001090. Ephrin_rcpt_lig-bd_dom. IPR003961. Fibronectin_type3. IPR008979. Galactose-bd-like. IPR013783. Ig-like_fold. IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR001660. SAM. IPR013761. SAM/pointed. IPR021129. SAM_type1. IPR001245. Ser-Thr/Tyr_kinase_cat_dom. IPR008266. Tyr_kinase_AS. IPR020635. Tyr_kinase_cat_dom. IPR016257. Tyr_kinase_ephrin_rcpt. IPR001426. Tyr_kinase_rcpt_V_CS. [Graphical view] | ||||||||||||||||||
| Pfam | PF01404. Ephrin_lbd. 1 hit. PF00041. fn3. 2 hits. PF07714. Pkinase_Tyr. 1 hit. PF00536. SAM_1. 1 hit. [Graphical view] | ||||||||||||||||||
| PIRSF | PIRSF000666. TyrPK_ephrin_receptor. 1 hit. | ||||||||||||||||||
| PRINTS | PR00109. TYRKINASE. | ||||||||||||||||||
| SMART | SM00615. EPH_lbd. 1 hit. SM00060. FN3. 2 hits. SM00454. SAM. 1 hit. SM00219. TyrKc. 1 hit. [Graphical view] | ||||||||||||||||||
| SUPFAM | SSF49265. FN_III-like. 2 hits. SSF49785. Gal_bind_like. 1 hit. SSF56112. Kinase_like. 1 hit. SSF47769. SAM_homology. 1 hit. | ||||||||||||||||||
| PROSITE | PS01186. EGF_2. 1 hit. Uncertain. PS51550. EPH_LBD. 1 hit. PS50853. FN3. 2 hits. PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00109. PROTEIN_KINASE_TYR. 1 hit. PS00790. RECEPTOR_TYR_KIN_V_1. 1 hit. PS00791. RECEPTOR_TYR_KIN_V_2. 1 hit. PS50105. SAM_DOMAIN. 1 hit. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| BindingDB | P54762. | ||||||||||||||||||
| ChEMBL | CHEMBL5072. | ||||||||||||||||||
| EvolutionaryTrace | P54762. | ||||||||||||||||||
| GenomeRNAi | 2047. | ||||||||||||||||||
| NextBio | 8321. | ||||||||||||||||||
| PMAP-CutDB | P54762. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | EPHB1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P54762 Secondary accession number(s): A8K593 Q0VG87 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| Human chromosome 3 Human chromosome 3: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
